Losing weight can feel like climbing a mountain with no clear path. The one-size-fits-all advice—like “eat less, move more”—rarely works because everyone’s body is different. That’s where personalized ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published, examining their ability to reduce weight and waist circumference. And one ...

Get the skinny on getting skinny. — -- Just in time for swimsuit season, a new study has come out saying there's very little scientific evidence to prove most diet and weight-loss regimens ...

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all these options stack up. Are there benefits to one over the other? How do side ...

In the first head-to-head comparison of two blockbuster drugs used in real-world conditions, people who took Mounjaro lost significantly more weight than their counterparts who took Ozempic — and the ...

Health care leaders and professionals constantly seek ways to improve their clients’ lifestyles. In recent times, nutritional programs have emerged as a tool that provides a balanced diet to drive ...

States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are searching for ways to get out from under the budgetary squeeze that took them by ...

The lowest doses of Eli Lilly’s Zepbound and Novo Nordisk's Wegovy could be available for as little as $149 a month.

The initial results demonstrate improved weight loss and high program satisfaction for CVS Caremark clients’ plan members trying a lifestyle-first approach, as well as additional clinical ...

Twenty-five years ago, when I started lifting, you could be strong in private. Your failures belonged to you. Now, every workout gets filmed, every lift gets posted, every personal record gets ...